Related Experiment Video
Updated: Mar 16, 2026
Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
Published on: May 3, 2024
Utility of Examination of Biopsy Tracts in Osteosarcoma Resection Specimens
1From the Department of Pathology, Vanderbilt University Medical Center, Nashville, TN. justin.m.cates@vanderbilt.edu.
Objectives:
To determine the utility and necessity of submitting tissue sections from the biopsy tracts of osteosarcoma resection specimens.
Methods:
The prevalence of residual tumor in representative sections of osteosarcoma biopsy tracts was assessed in a series of 97 osteosarcoma resection specimens.
Results:
No residual tumor cells were identified in 97 sampled biopsy tracts (0%; 95% confidence interval, 0%-2.5%).
Conclusions:
Pathologists do not need to submit sections of resected biopsy tracts unless there is clinical or gross evidence that would warrant further examination.
